ad image

Community

Marc Technow
Marc Technow

Contributor, Nice Insight

Marc has been a long-time friend of Pharma’s Almanac and has helped on numerous projects, such as editing texts and contributing to several strategic and journalistic articles. Marc has over seven years of experience in communications and holds a Master’s Degree in Arts from the University of Fresenius. He resides in Cologne, Germany.
13 Contributions1 / 1
Mental Health During a Global Pandemic
Mental Health

Mental Health During a Global Pandemic

Marc Technow

Nice Insight

PAO-06-022--NI-03Jun 24, 2022
Reflecting on COVID-19 in Germany
COVID-19 Impacts

Reflecting on COVID-19 in Germany

Marc Technow

Nice Insight

PAO-04-22-R221-22Apr 15, 2021
“Right To Try” Now Legal Across State Lines
Legislation

“Right To Try” Now Legal Across State Lines

Marc Technow

Nice Insight

PAO-M05-18-NI-026Jun 01, 2018
DOPING – Famous Cases, Substances and Values in Sports
Substance Control

DOPING – Famous Cases, Substances and Values in Sports

Marc Technow

Nice Insight

PAP-Q2-18-NI-003May 29, 2018
Study Shows AST-005 is Safe and Tolerable in Patients at Higher Doses than Previously Studied
Clinical Data

Study Shows AST-005 is Safe and Tolerable in Patients at Higher Doses than Previously Studied

Marc Technow

Nice Insight

PAO-M05-18-NI-003May 04, 2018
Gilead Sciences and Verily Life Sciences LLC Enter Collaboration, Hope to Better Understand Inflammatory Diseases
Inflammatory Disease

Gilead Sciences and Verily Life Sciences LLC Enter Collaboration, Hope to Better Understand Inflammatory Diseases

Marc Technow

Nice Insight

PAO-M05-18-NI-002May 04, 2018
Roche Expands Partnership with 4D Molecular Therapeutics to Treat Night Blindness
Strategic Partnership

Roche Expands Partnership with 4D Molecular Therapeutics to Treat Night Blindness

Marc Technow

Nice Insight

PAO-M05-18-NI-001May 04, 2018
Abzena’s New GMP Manufacturing Suite Expands ADC Chemistry Solutions at Bristol Site
Expanded Capacity

Abzena’s New GMP Manufacturing Suite Expands ADC Chemistry Solutions at Bristol Site

Marc Technow

Nice Insight

PR-M03-18-NI-105Mar 30, 2018
Partnership to Develop Clostridial-Based Medicines Moves Forward
Drug Development

Partnership to Develop Clostridial-Based Medicines Moves Forward

Marc Technow

Nice Insight

PR-M03-18-NI-104Mar 30, 2018
FUJIFILM Expands into Bio-Medical Business with Acquisition
Acquistion

FUJIFILM Expands into Bio-Medical Business with Acquisition

Marc Technow

Nice Insight

PR-M03-18-NI-103Mar 30, 2018
Adaptimmune’s GSK-Partnered T cells Trigger Responses in Solid Tumor Patients
Oncology

Adaptimmune’s GSK-Partnered T cells Trigger Responses in Solid Tumor Patients

Marc Technow

Nice Insight

PAO-M03-18-NI-023Mar 23, 2018
LANXESS Starts Production Line for Specialty Compounds in Germany
Production

LANXESS Starts Production Line for Specialty Compounds in Germany

Marc Technow

Nice Insight

PAO-M03-18-NI-022Mar 23, 2018
Tumor Derived T cells Demonstrate Potential Against Ovarian Cancer
Oncology

Tumor Derived T cells Demonstrate Potential Against Ovarian Cancer

Marc Technow

Nice Insight

PAO-M03-18-NI-020Mar 23, 2018
1 / 1